Skip to main content
Sports Medicine - Open

Table 2 Time trial as well as lung function variables and statistical outcomes

From: Acute Effects of Single Versus Combined Inhaled β2-Agonists Salbutamol and Formoterol on Time Trial Performance, Lung Function, Metabolic and Endocrine Variables

Variable

Treatment effect

Sex effect

Period effect

Time Trial performance

TT APO

[W]

–

wg

–

TT RPO

[%]

–

wg

–

Peak Power

[W]

–

wg

wg/m

Lung function testing

FVC %

predicted

–

–

f

(24 h Post–Pre-TT)

FEV1

[l/s]

Wg/m/f

(Post–Pre-TT)

–

–

FEV1%

predicted

wg/m/f

(Post–Pre-TT)

–

–

MEF 25

[l/s]

wg/m/f

(Post–Pre-TT)

–

–

MEF 25

predicted

wg/m/f

(Post–Pre-TT)

–

f

(Post–Pre-TT)

TLC

[l]

–

–

f

(Post–Pre-TT)

TLC %

predicted

–

–

f

(Post–Pre-TT)

sRaw

[kPa*s]

wg/f

(Post–Pre-TT)

–

–

  1. No treatment effect was found for any variable of time trial performance, while sex affected each of these variables
  2. TT Time trial, APO Average power output, RPO Relative power output, FVC Forced vital capacity, FEV1 Volume that has been exhaled at the end of the first second of forced expiration, TLC Total lung capacity, MEF Mean expiratory flow, sRaw Specific resistance of the airways, 24 h-/Post–Pre-TT Data compared between the lung function test time before and after the TT, Wg Whole group, f Female, m Male
Back to article page